Flagship Pioneering’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-19,575,710
| Closed | -$32.3M | – | 13 |
|
2022
Q1 | $32.3M | Hold |
19,575,710
| – | – | 0.76% | 10 |
|
2021
Q4 | $46.8M | Hold |
19,575,710
| – | – | 0.72% | 9 |
|
2021
Q3 | $107M | Hold |
19,575,710
| – | – | 1.12% | 8 |
|
2021
Q2 | $146M | Hold |
19,575,710
| – | – | 1.86% | 7 |
|
2021
Q1 | $159M | Buy |
19,575,710
+215,000
| +1% | +$1.74M | 2.54% | 8 |
|
2020
Q4 | $176M | Hold |
19,360,710
| – | – | 3.21% | 8 |
|
2020
Q3 | $214M | Hold |
19,360,710
| – | – | 5.92% | 3 |
|
2020
Q2 | $144M | Buy |
19,360,710
+2,000,000
| +12% | +$14.9M | 4.18% | 4 |
|
2020
Q1 | $107M | Hold |
17,360,710
| – | – | 5% | 4 |
|
2019
Q4 | $87.2M | Hold |
17,360,710
| – | – | 4.87% | 4 |
|
2019
Q3 | $131M | Hold |
17,360,710
| – | – | 7.15% | 3 |
|
2019
Q2 | $201M | Hold |
17,360,710
| – | – | 8.72% | 3 |
|
2019
Q1 | $252M | Buy |
+17,360,710
| New | +$252M | 9.53% | 3 |
|